Implication of Cannabinoids in Neurological Diseases

Author: Alsasua del Valle Angela  

Publisher: Springer Publishing Company

ISSN: 0272-4340

Source: Cellular and Molecular Neurobiology, Vol.26, Iss.4-6, 2006-07, pp. : 577-589

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

1. Preparations from Cannabis sativa (marijuana) have been used for many centuries both medicinally and recreationally.2. Recent advances in the knowledge of its pharmacological and chemical properties in the organism, mainly due to ∆9-tetrahydrocannabinol, and the physiological roles played by the endocannabinoids have opened up new strategies in the treatment of neurological and psychiatric diseases.3. Potential therapeutic uses of cannabinoid receptor agonists include the management of spasticity and tremor in multiple sclerosis/spinal cord injury, pain, inflammatory disorders, glaucoma, bronchial asthma, cancer, and vasodilation that accompanies advanced cirrhosis. CB1 receptor antagonists have therapeutic potential in Parkinson's disease.4. Dr. Julius Axelrod also contributed in studies on the neuroprotective actions of cannabinoids.